About Us

  1. You are here:  
  2. Home
  3. About Us
Image
Image
Advocating For Quality Pharma Products In The Health Sector

Developing people. Delivering results.

NIROPHARM is at the forefront of advocating and actively supporting in tangible ways the improvement of the Pharma Sector in Drug Availability, Affordability, Distribution and Quality across the entire Pharma Value Chain. 

Image
CORPORATE PROFILE
NIROPHARM is the Umbrella Body of Nigerian Representatives of Overseas Pharmaceutical Manufacturers, with a distinctive Research and Development Orientation that encompasses a wide variety of pharmaceutical marketing companies, but all with a common trait of representing one or many overseas pharmaceutical manufacturers.

people

EXECUTIVE TEAM

President
President

Femi Soremekun

General Secretary
General Secretary

Mrs Olayinka Oyeneyin

Vice President
Vice President

Sammy Ogunjinmi

Asst. General Secretary
Asst. General Secretary

Mrs Uchenna Adesugba

Financial Secretary
Financial Secretary

Charles Ajibo

Publicity Secretary
Publicity Secretary

Mrs Oluwayemisi Mafe

Treasurer
Treasurer

Adekunle Ademola

Ex-Officio
Ex-Officio

Mrs Yetunde Oyeneyin

Total Healthcare Services

Impact

Private Sector Provision of Healthcare Services (PharmAccess "Nigerian Health Sector Market Study Report" 2015)

Pharmaceuticals

Imports

A Large percentage of Pharmaceuticals in circulation in Nigeria

Pharmaceuticals 

Local Manufacture

Proportion of local manufactured pharmaceuticals in circulation.

Information

NIROPHARM is dedicated to working to improve and enhance the quality of service to the Nation, public (local and international) Image, and the scope of the Nigerian Pharmaceutical Industry who face a number of challenges. 

Some of the challenges that NIROPHRM is set  to tackle with all the resources it has at its disposal include: High cost of funds, Poor infrastructure, Poor IPR protection, Chaotic drug distribution, Lack of data for planning, High level of Counterfeiting, Low capacity of Regulatory Agencies, Regulatory Agency, not computerized, Poor surveillance particularly at the land borders